Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy

2001 ◽  
Vol 54 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Dong Il Kim ◽  
Myung-Hwan Kim ◽  
Sung Koo Lee ◽  
Dang Wan Seo ◽  
Won Boem Choi ◽  
...  
2018 ◽  
Vol 46 (7) ◽  
pp. 2595-2605 ◽  
Author(s):  
Sujuan Li ◽  
Bingzhong Su ◽  
Ping Chen ◽  
Jianyu Hao

Objective Late complications after endoscopic biliary sphincterotomy (EST) include stone recurrence, but no definite risk factors for recurrence have been established. This study was performed to identify the predictors of recurrence and evaluate the clinical outcomes of EST for common bile duct stones. Methods In total, 345 eligible patients who successfully underwent EST were evaluated and followed up. Statistical analysis was performed on patients with recurrence or who had undergone at least 6 months of reliable follow-up to detect the risk factors for recurrence. Results A total of 57 patients (16.52%) developed recurrence of common bile duct stones. The median length of time until recurrence was 10.25 months (range, 6–54.4 months). Univariate analyses showed that the following factors were associated with recurrence: cholecystectomy prior to EST, prior biliary tract surgery, periampullary diverticulum, diameter of the common bile duct (>15 vs. ≤15 mm), quantity of stones, complete stone removal at the first session, and lithotripsy. Multivariate analysis identified two independent risk factors for recurrence: previous biliary tract surgery and lithotripsy. Conclusions EST for common bile duct stones is safe as indicated by patients’ long-term outcomes. Patients with a history of biliary surgery or lithotripsy are more prone to recurrence.


2000 ◽  
Vol 51 (4) ◽  
pp. AB190
Author(s):  
Dong Il Kim ◽  
Myung Hwan Kim ◽  
Sung Koo Lee ◽  
Dong Wan Seo;Won Boem Choi ◽  
Sang Soo Lee ◽  
...  

2008 ◽  
Vol 134 (4) ◽  
pp. A-271
Author(s):  
Jung Mi Kim ◽  
Ho Soon Choi ◽  
Dong Hee Koh ◽  
Won Moon ◽  
Seung Chul Cho ◽  
...  

2006 ◽  
Vol 63 (5) ◽  
pp. AB287 ◽  
Author(s):  
Matthew Carnes ◽  
Peter B. Cotton ◽  
Robert H. Hawes ◽  
Christopher Lawrence ◽  
Mark Payne ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Ju Hyun Oak ◽  
Chang Nyol Paik ◽  
Woo Chul Chung ◽  
Kang-Moon Lee ◽  
Jin Mo Yang

Purpose. The recurrence of CBD stone is still observed in a considerable number of patients. The study was to evaluate the risk factors for recurrence of symptomatic CBD stone in patients who underwent cholecystectomy after the removal of CBD stone.Methods. The medical records of patients who underwent removal of CBD stone with subsequent cholecystectomy were reviewed. The risk factors for the recurrence of symptomatic CBD stone were compared between the recurrence and the nonrecurrence group.Results. The mean follow-up period was 40.6 months. The recurrence of symptomatic CBD stones was defined as the detection of bile duct stones no sooner than 6 months after complete clearance of CBD stones, based on symptoms or signs of biliary complication. 144 patients (68 males, 47.2%) were finally enrolled and their mean age was 59.8 (range: 26~86) years. The recurrence of CBD stone occurred in 15 patients (10.4%). The mean period until first recurrence was 25.9 months. The presence of type 1 or 2 periampullary diverticulum and multiple CBD stones were the independent risk factors.Conclusion. For the patients with type 1 or 2 periampullary diverticulum or multiple CBD stones, careful followup is needed for the risk in recurrence of symptomatic CBD stone.


Sign in / Sign up

Export Citation Format

Share Document